These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
374 related articles for article (PubMed ID: 27994495)
21. Association of a novel circulating tumor DNA next-generating sequencing platform with circulating tumor cells (CTCs) and CTC clusters in metastatic breast cancer. Davis AA; Zhang Q; Gerratana L; Shah AN; Zhan Y; Qiang W; Finkelman BS; Flaum L; Behdad A; Gradishar WJ; Platanias LC; Cristofanilli M Breast Cancer Res; 2019 Dec; 21(1):137. PubMed ID: 31801599 [TBL] [Abstract][Full Text] [Related]
22. Nanotechnology Strategies for the Analysis of Circulating Tumor DNA: A Review. Chen X; Wang L; Lou J Med Sci Monit; 2020 Mar; 26():e921040. PubMed ID: 32200389 [TBL] [Abstract][Full Text] [Related]
23. Metastatic Melanoma: Liquid Biopsy as a New Precision Medicine Approach. Ricciardi E; Giordani E; Ziccheddu G; Falcone I; Giacomini P; Fanciulli M; Russillo M; Cerro M; Ciliberto G; Morrone A; Guerrisi A; Valenti F Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835424 [TBL] [Abstract][Full Text] [Related]
24. The potential of liquid biopsy in the management of cancer patients. Markou A; Tzanikou E; Lianidou E Semin Cancer Biol; 2022 Sep; 84():69-79. PubMed ID: 35331850 [TBL] [Abstract][Full Text] [Related]
25. Clinical Application of Liquid Biopsy in Pancreatic Cancer: A Narrative Review. Ramírez-Maldonado E; López Gordo S; Major Branco RP; Pavel MC; Estalella L; Llàcer-Millán E; Guerrero MA; López-Gordo E; Memba R; Jorba R Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338919 [TBL] [Abstract][Full Text] [Related]
26. Research progress on liquid biopsy in oncology and its clinical applications. Wang C; Li YM; Fang XD Yi Chuan; 2017 Mar; 39(3):220-231. PubMed ID: 28420618 [TBL] [Abstract][Full Text] [Related]
27. PIK3CA hotspot mutations in circulating tumor cells and paired circulating tumor DNA in breast cancer: a direct comparison study. Tzanikou E; Markou A; Politaki E; Koutsopoulos A; Psyrri A; Mavroudis D; Georgoulias V; Lianidou E Mol Oncol; 2019 Dec; 13(12):2515-2530. PubMed ID: 31254443 [TBL] [Abstract][Full Text] [Related]
28. Circulating tumor DNA as a predictive marker for occult metastases in pancreatic cancer patients with radiographically non-metastatic disease. Hata T; Mizuma M; Iseki M; Takadate T; Ishida M; Nakagawa K; Hayashi H; Morikawa T; Motoi F; Unno M J Hepatobiliary Pancreat Sci; 2021 Aug; 28(8):648-658. PubMed ID: 34022116 [TBL] [Abstract][Full Text] [Related]
29. The feasibility of using mutation detection in ctDNA to assess tumor dynamics. Yi X; Ma J; Guan Y; Chen R; Yang L; Xia X Int J Cancer; 2017 Jun; 140(12):2642-2647. PubMed ID: 28124376 [TBL] [Abstract][Full Text] [Related]
30. Exploring the Clinical Utility of Pancreatic Cancer Circulating Tumor Cells. Yeo D; Bastian A; Strauss H; Saxena P; Grimison P; Rasko JEJ Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163592 [TBL] [Abstract][Full Text] [Related]
31. Unveiling the impact of circulating tumor cells: Two decades of discovery and clinical advancements in solid tumors. Reduzzi C; Nicolo' E; Singhal S; Venetis K; Ortega-Franco A; de Miguel-Perez D; Dipasquale A; Gouda MA; Saldanha EF; Kasi PM; Jantus-Lewintre E; Fusco N; Malapelle U; Gandara DR; Rolfo C; Serrano MJ; Cristofanilli M; Crit Rev Oncol Hematol; 2024 Nov; 203():104483. PubMed ID: 39159706 [TBL] [Abstract][Full Text] [Related]
32. Tracking cancer progression: from circulating tumor cells to metastasis. Castro-Giner F; Aceto N Genome Med; 2020 Mar; 12(1):31. PubMed ID: 32192534 [TBL] [Abstract][Full Text] [Related]
33. The emerging role of liquid biopsy in diagnosis, prognosis and treatment monitoring of pancreatic cancer. Rofi E; Vivaldi C; Del Re M; Arrigoni E; Crucitta S; Funel N; Fogli S; Vasile E; Musettini G; Fornaro L; Falcone A; Danesi R Pharmacogenomics; 2019 Jan; 20(1):49-68. PubMed ID: 30520336 [TBL] [Abstract][Full Text] [Related]
34. Detection of circulating tumor DNA from non-small cell lung cancer brain metastasis in cerebrospinal fluid samples. Ma C; Yang X; Xing W; Yu H; Si T; Guo Z Thorac Cancer; 2020 Mar; 11(3):588-593. PubMed ID: 31944608 [TBL] [Abstract][Full Text] [Related]
35. Circulating tumor markers: harmonizing the yin and yang of CTCs and ctDNA for precision medicine. Batth IS; Mitra A; Manier S; Ghobrial IM; Menter D; Kopetz S; Li S Ann Oncol; 2017 Mar; 28(3):468-477. PubMed ID: 27998963 [TBL] [Abstract][Full Text] [Related]
36. Base-Position Error Rate Analysis of Next-Generation Sequencing Applied to Circulating Tumor DNA in Non-Small Cell Lung Cancer: A Prospective Study. Pécuchet N; Zonta E; Didelot A; Combe P; Thibault C; Gibault L; Lours C; Rozenholc Y; Taly V; Laurent-Puig P; Blons H; Fabre E PLoS Med; 2016 Dec; 13(12):e1002199. PubMed ID: 28027313 [TBL] [Abstract][Full Text] [Related]
37. Circulating tumor cells in the clinical cancer diagnosis. Zhang P; Zhou H; Lu K; Wang Y; Feng T Clin Transl Oncol; 2020 Mar; 22(3):279-282. PubMed ID: 31140068 [TBL] [Abstract][Full Text] [Related]
38. Recent advances in circulating tumor cells and cell-free DNA in metastatic prostate cancer: a review. Parimi S; Ko JJ Expert Rev Anticancer Ther; 2017 Oct; 17(10):939-949. PubMed ID: 28737470 [TBL] [Abstract][Full Text] [Related]
40. Liquid biopsy in pancreatic ductal adenocarcinoma: current status of circulating tumor cells and circulating tumor DNA. Lee JS; Park SS; Lee YK; Norton JA; Jeffrey SS Mol Oncol; 2019 Aug; 13(8):1623-1650. PubMed ID: 31243883 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]